Bactericidal Activity of Serum for Klebsiella Rhinoscleromatis: Studies on Serum from a Patient with Rhinoscleroma and Sera Deficient in Antibody or Complement

References

1. Krasilnikov A. P., Izraitel N. A., Shimanovich S. V. 1974; Immune inhibition of bactericidal activity of sera. Report 1. Bactericidal activity of the sera of healthy persons and those suffering from scleroma and its inhibition by specific antibodies. Zh. Mikrobiol. Epidem. Immunobioi 1:50 in Russian
   [Google Scholar]
2. Martin A., Lachmann P.J. 1977; Haemolytic assays in agarose plates for components of the classical complement pathway: interference by the alternative pathway. Clin. exp. Immun. 27:13
   [Google Scholar]
3. Michael J. G., Whitby J. L., Landy M. 1962; Studies on natural antibodies to gram-negative bacteria. J. exp. Med. 115:131
   [Google Scholar]
4. Muzyka M.M., Gubina K.M. 1972; Problems of the epidemiology of scleroma. Report No. 2. Some aspects of the problem of endemic focus formation. J. Hyg. Epidem. Microbiol. Immun. 16:8
   [Google Scholar]
5. Nakajima S., Nihei K., Hyodo Y. 1978; C3 activator in agammaglobulinemia. Int. Archs Allergy appl. Immun. 56:563
   [Google Scholar]
6. Reed W. P., Albright E. L. 1974; Serum factors responsible for killing of Shigella. Immunology 26:205
   [Google Scholar]
7. Schenkein H. A., Ruddy S. 1981; The role of immunoglobulins in alternative complement pathway activation by zymosan. 1. Human IgG with specificity for zymosan enhances alternative pathway activation for zymosan. J. Immun. 126:7
   [Google Scholar]
8. Schreiber R. D., Morrison D. C, Podack E. R., Muller-Eberhard H. J. 1979; Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins. J. exp. Med. 149:870
   [Google Scholar]